Last updated on February 2018
Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
Brief description of study
This prospective cohort study will investigate whether progression of the interstitial lung diseases is related to specific clinical endpoints and their changes over time. Longitudinal data of patients will be compared to an age-matched control group during a follow-up of at least two years.
Clinical Study Identifier: NCT03400839